DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 3.23% to $8.08 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.26% to 17,382.94 and the Dow Jones Industrial Average rising 0.05% to 40,113.50.
The stock's fall snapped a five-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 86.95% short of its 52-week high of $61.90, which the company reached on July 31st.
The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.39% to $4.25, Fortress Biotech Inc. (FBIO) fell 1.20% to $1.64, and Viking Therapeutics Inc. $(VKTX)$ fell 2.61% to $24.99.
Trading volume (225,905) remained 5,221 below its 50-day average volume of 231,126.
Data source: Dow Jones Market Data, FactSet. Data compiled April 25, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 25, 2025 17:23 ET (21:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。